Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643162 · ClinicalTrials.gov registry record · NA
Combination Lexapro and Massage for Treatment of Depression in Older Adults
A NA study, sponsored by Cedars-Sinai Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT00643162 is a NA study that was terminated before completion, run by Cedars-Sinai Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT00643162, a NA study, was terminated before completion, sponsored by Cedars-Sinai Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
Depression is a common and disabling condition which represents a substantial public health concern, especially with the aging of the population in general. In fact, one to four percent of the older population has major depression. Although medication is the main treatment for depression, studies show that only 50% of patients show a significant response to treatment. The response might actually be less in older subjects, and with more adverse side effects due to changes in the metabolism of the older population as well as drug interaction. For these reasons (changes in metabolism and possible drug interactions) the starting dose of the antidepressant Lexapro will be 5mg, instead of 10mg. To combat the incomplete response to medication, many combined and augmentation strategies have been developed. Examples of this would be an antidepressant medication plus a neuroleptic medication; or an antidepressant medication plus talk therapy. One non-medication treatment that is being considered is massage therapy. Recent data suggest that massage therapy can be useful for the treatment of depression. This study proposes to perform a controlled trail to assess the effects of massage therapy on symptoms of depression in older subjects with major depression. All of the subjects will receive Lexapro, which is an FDA approved medication for the treatment of depression. Half of the subjects will receive Swedish massage for one hour, twice a week, and the other half will receive light touch for one hour, twice per week for eight weeks. Standardized rating scales that evaluate depression will be used to evaluate the subjects mood.
Interventions
- DRUG Lexapro
- BEHAVIORAL Massage
- BEHAVIORAL Light touch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-06 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00643162
The ClinicalTrials.gov registry entry for NCT00643162 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lexapro is the first listed.
NCT00643162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00643162 about?
NCT00643162 is a clinical study titled "Combination Lexapro and Massage for Treatment of Depression in Older Adults". Depression is a common and disabling condition which represents a substantial public health concern, especially with the aging of the population in general. In fact, one to four percent of the older population has major depression. Although medication is the main treatment for depression, studies sh...
What is the current status of trial NCT00643162?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2006-06. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00643162?
The interventions under investigation include: Lexapro (DRUG), Massage (BEHAVIORAL), Light touch (BEHAVIORAL).
Who is sponsoring clinical trial NCT00643162?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.